Next, in light of previous evidence that ROPI effectively decreased ROS levels in MNs with the TARDBP mutation, which may be important for ALS pathology, we investigated whether ROPI plays a role in reducing ROS production via the dopamine signaling pathway. The gene discussed is TARDBP; the disease is amyotrophic lateral sclerosis.